@article{1d337b4e2dd8493182471314965877da,
title = "Reply: The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy: More questions than answers?",
author = "Eloisa Arbustini and Navneet Narula and {William Dec}, G. and {Srinath Reddy}, K. and Barry Greenberg and Sudhir Kushwaha and Thomas Marwick and Sean Pinney and Riccardo Bellazzi and Valentina Favalli and Christopher Kramer and Robert Roberts and Zoghbi, {William A.} and Robert Bonow and Luigi Tavazzi and Valentin Fuster and Jagat Narula",
note = "Funding Information: Please note: This study was supported by Grants European Union INHERITANCE project n _ 241924 and Italian Ministry of Health “Diagnosis and Treatment of Hypertrophic Cardiomyopathies” (n _ RF-PSM-2008-1145809) to E.A., IRCCS Policlinico San Matteo, Pavia. Dr. Greenberg is a consultant for Zensun, Celladon, Mesoblast, Novartis, and Teva Pharmaceutical; and is on the Speakers' Bureaus of Otsuka and Boehringer Ingelheim. Dr. Kramer has received research support from Novartis (research funding) and Siemens Healthcare (equipment); and is a consultant for Synarc and St. Jude Medical. Dr. J. Narula has received research grants from GE Healthcare and Phillips. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. ",
year = "2014",
month = jun,
day = "17",
doi = "10.1016/j.jacc.2014.03.028",
language = "English (US)",
volume = "63",
pages = "2584--2586",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier",
number = "23",
}